Cart summary

You have no items in your shopping cart.

Anticancer agent 259

SKU: orb2814675

Description

Anticanceragent 259 (Compound 3g) is a telmisartan-derived small molecule that acts as a STAT5 pathway inhibitor, resensitizing imatinib-resistant cells with an SC50 of 1.5 µM. It is a valuable research tool for studying STAT5-dependent signaling and overcoming drug resistance in hematological cancers, as demonstrated in in vitro studies.

Research Area

Signal Transduction, Stem Cell & Developmental Biology

Images & Validation

Key Properties

MW446.54
FormulaC30H26N2O2
TargetSTAT

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Anticancer agent 259 (orb2814675)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%